Randomized trial, comparative with placebo, double blind, to evaluate the effect of the treatment with 320 mg/d of megestrol acetate in patients with severe chronic obstructive pulmonary disease (COPD) and loss of body weight. Pilot study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Megestrol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 07 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2011 Biomarkers information updated
- 23 Jan 2009 Planned end date changed from 1 Apr 2009 to 1 Sep 2009.